Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Shortage of API:...

    Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-26T13:14:36+05:30  |  Updated On 26 March 2020 2:38 PM IST
    Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

    Kolkata: PSU pharma company Bengal Chemicals and Pharmaceuticals Ltd (BPCL) on Tuesday said it can provide only a maximum of 10 lakh hydroxy-chloroquine tablets due to the shortage of a key component, Active Pharmaceutical Ingredient (API).

    The Indian Council of Medical Research (ICMR) has recommended the use of hydroxy-chloroquine for healthcare workers involved in the care of suspected or confirmed Covid-19 cases and the asymptomatic household contacts of lab-confirmed cases as a preventive treatment measure.

    Bengal Chemicals is possibly the only company from this part of the country having the capacity to produce hydroxy-chloroquine.

    "Whatever raw material (API) we have that can be good for only 10 lakh malaria tablets (having hydroxy-chloroquine)," BPCL managing director PM Chandraiah told.

    API is the term used to refer to the biologically active component of a drug product such as a tablet, capsule.

    India imports 80 percent of API from China, from where the novel coronavirus originated, to meet its requirements.

    "In India, only the private sector IPCA produces API and we had been told that we are in the queue and our turn will come in May-June," he said.

    According to the data updated Tuesday morning, the total number of COVID-19 cases rose to 492, including 446 active cases.

    Bengal Chemicals & Pharmaceuticals Ltd. located in Kolkata, West Bengal.

    It is a Public Sector Undertaking in founded in 1901 by Prafulla Chandra Ray.

    Today, BCPL is a Chemicals & Pharmaceuticals Company with a diversified range of brands to support cleanliness, health, and hygiene in every sphere of our life.

    Recently the unique cleanliness brands of BCPL were recommended by Govt. of India for "SWACCH BHARAT MISSION" envisioned by our Honourable Prime Minister.

    It manufactures anti-snake venom serum (ASVS), Hospitol, naphthalene balls, Phenyl etc.

    Following over 6 decades of losses, BCPL posted a profit of ₹4 crores (US$560,000) in the fiscal year 2016-17.is a Public Sector Undertaking (PSU).

    Read also: Novartis to donate up to 130 million doses of hydroxychloroquine for COVID-19


    bengal-chemicals-and-pharmaceuticalshydroxy-chloroquine-tabletsapiactive-pharmaceutical-ingredient
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok